Unresectable Liposarcoma
📧 Sign up to get email alerts when something new happens for Unresectable Liposarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma [Phase 1, Phase 2]
This update reports on a Phase 1/2 clinical trial evaluating the MEK inhibitor mirdametinib in combination with palbociclib for liposarcoma,…
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Clinical trial evaluating avelumab plus trabectedin in metastatic or unresectable liposarcoma and leiomyosarcoma; the study has terminated w…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating nivolumab with or without ipilimumab in metastatic or unresectable sarcoma shows results from a completed study.